Blood News and Research

RSS

Lone star tick bites are likely the cause of severe red meat allergies

Lone star tick bites are likely the cause of thousands of cases of severe red meat allergies that are plaguing patients in Southeastern states including Tennessee, North Carolina and Virginia and spreading up the Eastern Seaboard along with the deer population.

21 Feb 2014

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Most people have heard of severe allergies, or anaphylaxis, to food, insect stings, drugs and other common substances, but sometimes no cause at all can be found for a person’s reaction – a condition called Idiopathic anaphylaxis.

21 Feb 2014

Viewpoints: Democrats turn tail; amending ACA is tough; Belgium takes hard stance on dying kids

Democrats in competitive races seem to have gotten hall passes to try to dissociate themselves from ObamaCare heading into the midterm elections, but the White House must be ruing some of the liberties their party comrades are taking with this new political independence. Witness the parade of Democrats pleading for more money for that great liberal anathema, Medicare Advantage (2/19).

21 Feb 2014

XenoPort reports net loss of $19.1 million for fourth quarter 2013

XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.

20 Feb 2014

CSL Behring enrolls first patient in phase III study of C1-INH for prevention of HAE attacks

CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor oncentrate in patients with frequent hereditary angioedema attacks (NCT01912456).

20 Feb 2014

Study finds Cyclin A2 protein induces cardiac regeneration after myocardial infarction

After a heart attack, there is often permanent damage to a portion of the heart. This happens, in part, because cardiac muscle cells are terminally differentiated and cannot proliferate after blood flow is blocked off to the heart.

20 Feb 2014

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.

20 Feb 2014

BettrLife, Withings partner to jointly promote interactive mobile healthcare applications and products

Health and wellness technology leader BettrLife, and pioneer in consumer connected health devices Withings, have announced a business partnership to jointly promote their interactive mobile healthcare applications and products.

20 Feb 2014

Support for progranulin role in bipolar disorder

Researchers have found reduced levels of plasma progranulin in patients with bipolar disorder, strengthening evidence for its possible role as a biomarker for the condition.

20 Feb 2014

Medicines that mimic body's natural systems can prevent debilitating side effects

Debilitating side effects associated with prescription medication for some of today's most common conditions could be eradicated if they mimicked the body's natural hormone secretion cycles, a new report has said.

20 Feb 2014

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Larry Ambrose woke up one night, wandered into his kitchen but couldn't completely read the time on his microwave. A few days later when he noticed his blood pressure was unusually high, he went to the hospital and was diagnosed as having a stroke.

From Medtronic 20 Feb 2014

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.

20 Feb 2014

Ten researchers receive 2014 Heinz Maier-Leibnitz Prizes

This year's recipients of the most important prize for early career researchers in Germany have been announced. The selection committee, appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF), has chosen ten researchers, three women and seven men, to receive the 2014 Heinz Maier-Leibnitz Prizes.

20 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Guerbet: FDA approves manufacturing plant for Lipiodol (ethiodized oil) Injection

Guerbet (GBT), the contrast agent specialist for medical imaging, today announced that it had received approval from the U.S. Food and Drug Administration (FDA) for a new manufacturing plant for Lipiodol® (ethiodized oil) Injection, in Montreal, Canada.

20 Feb 2014

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.

20 Feb 2014

Research shows that seasonal flu vaccination may reduce risk of stroke

Having the seasonal flu jab could reduce the risk of suffering a stroke by almost a quarter, researchers have found.

20 Feb 2014

Purdue’s new innovation improves drug therapies by making real-time decisions about treatment options

Oncologists and cancer patients could improve the results of drug therapies by making real-time decisions about treatment options using an innovation developed in Purdue University's College of Pharmacy.

20 Feb 2014

New method enables scientists to print tissue constructs with blood vessels

A new bioprinting method developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard School of Engineering and Applied Sciences (SEAS) creates intricately patterned 3D tissue constructs with multiple types of cells and tiny blood vessels.

20 Feb 2014

Study to understand how stress related to risk of developing heart disease and stroke in women

Loyola University Chicago Marcella Niehoff School of Nursing researchers are recruiting women for a study to better understand how early life adversity and stress over one's lifetime are related to risk of developing heart disease and stroke in African American women compared to non-Hispanic white women.

20 Feb 2014

Blood News and Research

Lone star tick bites are likely the cause of severe red meat allergies

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Viewpoints: Democrats turn tail; amending ACA is tough; Belgium takes hard stance on dying kids

XenoPort reports net loss of $19.1 million for fourth quarter 2013

CSL Behring enrolls first patient in phase III study of C1-INH for prevention of HAE attacks

Study finds Cyclin A2 protein induces cardiac regeneration after myocardial infarction

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

BettrLife, Withings partner to jointly promote interactive mobile healthcare applications and products

Support for progranulin role in bipolar disorder

Medicines that mimic body's natural systems can prevent debilitating side effects

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Ten researchers receive 2014 Heinz Maier-Leibnitz Prizes

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Guerbet: FDA approves manufacturing plant for Lipiodol (ethiodized oil) Injection

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Research shows that seasonal flu vaccination may reduce risk of stroke

Purdue’s new innovation improves drug therapies by making real-time decisions about treatment options

New method enables scientists to print tissue constructs with blood vessels

Study to understand how stress related to risk of developing heart disease and stroke in women

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News